About Vivostat
Vivostat is a company based in Allerød (Denmark) founded in 2001 was acquired by Principal Technologies in February 2024.. Vivostat has raised $12.89 million across 6 funding rounds from investors including European Union, Principal Technologies and EIC Fund. Vivostat offers products and services including Vivostat System, ArthroZheal, Obsidian ASG, Obsidian RFT, and Vivostat Fibrin. Vivostat operates in a competitive market with competitors including PrognomiQ, PreOmics, LenioBio, Expedeon and List Biological Laboratories, among others.
- Headquarter Allerød, Denmark
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vivostat A/S
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.89 M (USD)
in 6 rounds
-
Latest Funding Round
$55.08 K (USD), Grant
Apr 30, 2023
-
Investors
European Union
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Principal Technologies
(Feb 06, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vivostat
Vivostat offers a comprehensive portfolio of products and services, including Vivostat System, ArthroZheal, Obsidian ASG, Obsidian RFT, and Vivostat Fibrin. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for on-site preparation of autologous fibrin for surgery
Matrix for arthroscopic surgery to support tissue regeneration
Matrix for gastrointestinal surgery to aid healing
Matrix for fistula treatment in minimally invasive procedures
Sealant for surgical applications to promote hemostasis
Funding Insights of Vivostat
Vivostat has successfully raised a total of $12.89M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $55.08 thousand completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $55,079
-
First Round
First Round
(04 Feb 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Grant - Vivostat | Valuation |
investors |
|
| May, 2021 | Amount | Grant - Vivostat | Valuation |
investors |
|
| Apr, 2020 | Amount | Grant - Vivostat | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vivostat
Vivostat has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Principal Technologies and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Healthcare investments are targeted by Principal Technologies private equity fund.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vivostat
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vivostat
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vivostat Comparisons
Competitors of Vivostat
Vivostat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, PreOmics, LenioBio, Expedeon and List Biological Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
Reagents and instruments for proteomics research are supplied by PreOmics.
|
|
| domain | founded_year | HQ Location |
Kits for cell-free eukaryotic protein expression are provided.
|
|
| domain | founded_year | HQ Location |
Reagents and kits for protein-based research are developed and supplied.
|
|
| domain | founded_year | HQ Location |
Specializes in the production of research reagents
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vivostat
Frequently Asked Questions about Vivostat
When was Vivostat founded?
Vivostat was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Where is Vivostat located?
Vivostat is headquartered in Allerød, Denmark.
Is Vivostat a funded company?
Vivostat is a funded company, having raised a total of $12.89M across 6 funding rounds to date. The company's 1st funding round was a Grant of $54.29K, raised on Feb 04, 2007.
What does Vivostat do?
Vivostat was founded in 2001 in Alleroed, Denmark, and operates in the medical device sector focused on autologous blood processing. Systems for on-site preparation of fibrin sealants are developed, with the Vivostat system enabling reproducible platelet-rich plasma production without cryoprecipitation or external thrombin. The setup includes a processor for blood handling, an applicator for site-specific delivery, and disposable collection components, supporting surgical applications across clinical settings.
Who are the top competitors of Vivostat?
What products or services does Vivostat offer?
Vivostat offers Vivostat System, ArthroZheal, Obsidian ASG, Obsidian RFT, and Vivostat Fibrin.
Who are Vivostat's investors?
Vivostat has 3 investors. Key investors include European Union, Principal Technologies, and EIC Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.